Startseite Naturwissenschaften Synthesis and crystal structure of ((6R,7S)-3-ethyl-6-phenyl-6,7-dihydro-5H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazin-7-yl)(phenyl)methanone hemihydrate, 2(C19H18N4OS) ⋅ H2O
Artikel Open Access

Synthesis and crystal structure of ((6R,7S)-3-ethyl-6-phenyl-6,7-dihydro-5H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazin-7-yl)(phenyl)methanone hemihydrate, 2(C19H18N4OS) ⋅ H2O

  • Qichun Ding ORCID logo EMAIL logo , Ruya Yang und Peipao Yao
Veröffentlicht/Copyright: 20. Juni 2020
Artikel downloaden (PDF)
Veröffentlichen auch Sie bei De Gruyter Brill
Manuskript einreichen Informationen für Autor*innen
Zeitschrift für Kristallographie - New Crystal Structures
Aus der Zeitschrift Zeitschrift für Kristallographie - New Crystal Structures Band 235 Heft 5

Abstract

C38H38N8O3S2, triclinic, P1̄ (no. 2), a = 10.1773(12) Å, b = 12.9096(15) Å, c = 15.1950(18) Å, α = 97.579(1)°, β = 97.967(1)°, γ = 109.835(1)°, V = 1825.2(4) Å3, Z = 2, Rgt(F) = 0.0523, wRref(F2) = 0.1412, T = 296.15 K.

CCDC no.: 2006280

The molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Block
Size:0.27 × 0.26 × 0.24 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:0.20 mm−1
Diffractometer, scan mode:Bruker APEX-II, φ and ω
θmax, completeness:27.6°, >99%
N(hkl)measured, N(hkl)unique, Rint:14724, 7804, 0.016
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 5694
N(param)refined:526
Programs:Bruker [1], Olex2 [2], SHELX [3]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
C1−0.2435(3)0.2258(2)0.9373(2)0.0665(7)
H1−0.3394890.1925980.9389960.080*
C2−0.1549(3)0.3106(2)1.00634(19)0.0676(7)
H2−0.1914410.3356581.0541210.081*
C3−0.0120(2)0.3588(2)1.00537(16)0.0533(5)
H30.0475210.4161161.0526260.064*
C40.0440(2)0.32222(16)0.93393(13)0.0368(4)
C5−0.0475(2)0.23829(18)0.86343(15)0.0490(5)
H5−0.0126370.2142710.8143800.059*
C6−0.1914(2)0.1899(2)0.86581(19)0.0643(7)
H6−0.2521870.1329660.8187140.077*
C70.1999(2)0.37287(17)0.93830(13)0.0399(4)
C80.2619(2)0.33793(17)0.85840(13)0.0385(4)
H80.1991540.2627000.8258930.046*
C90.41296(19)0.33767(17)0.88998(12)0.0382(4)
H90.4749270.4126860.9234010.046*
C100.3950(2)0.43431(18)0.72978(14)0.0465(5)
C110.4091(2)0.25366(17)0.95106(13)0.0393(4)
C120.4857(2)0.2899(2)1.03908(14)0.0497(5)
H120.5350940.3661601.0612480.060*
C130.4894(3)0.2135(3)1.09441(16)0.0632(7)
H130.5412870.2387251.1534620.076*
C140.4173(3)0.1010(3)1.06281(19)0.0686(7)
H140.4205630.0500931.1002040.082*
C150.3401(3)0.0636(2)0.97592(19)0.0657(7)
H150.290676−0.0127880.9543910.079*
C160.3360(2)0.13975(19)0.92018(16)0.0517(5)
H160.2833520.1139510.8613280.062*
C17a0.5726(6)0.4007(5)0.6927(4)0.0484(11)
C18a0.6935(6)0.3590(5)0.6944(3)0.0581(12)
H18Aa0.7192460.3548430.6353060.070*
H18Ba0.6637860.2841520.7081270.070*
C19a0.8220(6)0.4366(5)0.7651(4)0.0811(16)
H19Aa0.8520700.5104790.7511610.122*
H19Ba0.8982450.4087060.7651900.122*
H19Ca0.7969130.4397150.8237980.122*
C200.8375(4)0.2481(4)0.2969(2)0.0949(11)
H200.9260930.2801000.2818150.114*
C210.7734(4)0.1352(4)0.2817(2)0.0941(10)
H210.8187270.0900350.2571430.113*
C220.6428(3)0.0872(3)0.30232(18)0.0702(7)
H220.5988140.0094830.2905140.084*
C230.5744(2)0.1532(2)0.34080(14)0.0488(5)
C240.6415(3)0.2680(2)0.35689(18)0.0647(7)
H240.5980440.3135890.3831630.078*
C250.7727(3)0.3162(3)0.3344(2)0.0862(9)
H250.8169300.3938760.3445630.103*
C260.4335(2)0.0953(2)0.36268(14)0.0508(5)
C270.3657(2)0.1605(2)0.42094(14)0.0503(5)
H270.4123830.2410780.4232690.060*
C280.2638(3)0.15025(19)0.57725(14)0.0538(6)
C290.2044(2)0.12390(19)0.38401(13)0.0452(5)
H290.1596390.0437990.3845220.054*
C300.1746(2)0.14087(18)0.28733(13)0.0424(5)
C310.0824(2)0.0515(2)0.22193(14)0.0493(5)
H310.040891−0.0179180.2375480.059*
C320.0513(3)0.0641(2)0.13373(15)0.0618(6)
H32−0.0103660.0031470.0900670.074*
C330.1111(3)0.1664(2)0.11017(16)0.0678(7)
H330.0896410.1749630.0506780.081*
C340.2024(3)0.2558(2)0.17429(17)0.0684(7)
H340.2429290.3251470.1583170.082*
C350.2348(3)0.2435(2)0.26293(16)0.0583(6)
H350.2972300.3044850.3062110.070*
C36b0.071(4)0.173(5)0.584(4)0.059(3)
C37b−0.081(3)0.165(2)0.5537(17)0.066(3)
H37Ab−0.1171990.1223500.4924060.079*
H37Bb−0.1445750.1310990.5924830.079*
C38b−0.066(2)0.276(3)0.5568(13)0.085(4)
H38Ab−0.1581660.2820920.5479860.128*
H38Bb−0.0177500.3040260.5098020.128*
H38Cb−0.0110630.3200640.6146190.128*
N10.47500(18)0.30655(15)0.81389(11)0.0452(4)
H1A0.4337050.2372760.7877350.054*
N20.48464(18)0.38140(15)0.75320(12)0.0463(4)
N30.4321(2)0.48750(18)0.66437(14)0.0652(6)
N40.5512(3)0.4667(2)0.64418(16)0.0778(7)
N50.13590(19)0.18472(17)0.43789(11)0.0503(4)
H5A0.1596040.2540070.4330010.060*
N60.1548(2)0.17005(16)0.52867(11)0.0506(4)
N70.2415(3)0.14128(17)0.65939(12)0.0637(6)
N80.1137(3)0.15671(18)0.66420(13)0.0678(6)
O10.27862(16)0.44176(14)1.00343(11)0.0603(4)
O20.3700(2)−0.00529(16)0.33684(13)0.0739(5)
O30.2769(2)0.42970(19)0.47432(13)0.0894(7)
S10.25895(6)0.44010(5)0.78554(4)0.05375(17)
S20.40207(9)0.12811(8)0.53420(4)0.0805(3)
H3A0.336(3)0.462(3)0.4430(17)0.121*
H3B0.316(3)0.449(3)0.5300(8)0.121*
C19Ac0.8665(12)0.4765(11)0.7243(10)0.070(3)
H19Dc0.8599010.4937760.6646420.105*
H19Ec0.9455940.4526120.7370920.105*
H19Fc0.8804340.5421200.7679070.105*
C18Ac0.7313(17)0.3842(14)0.7292(12)0.059(3)
H18Cc0.7159830.3189700.6835570.071*
H18Dc0.7413160.3630750.7880290.071*
C17Ac0.6121(18)0.4161(17)0.7158(12)0.054(3)
C37Ad−0.0682(11)0.2028(12)0.5590(7)0.0684(19)
H37Cd−0.1209150.1593700.4997550.082*
H37Dd−0.1287540.1807830.6024440.082*
C36Ad0.0589(16)0.172(2)0.5857(14)0.0579(15)
C38Ad−0.0358(12)0.3264(13)0.5578(5)0.075(2)
H38Dd0.0091550.3696160.6174880.113*
H38Ed−0.1228290.3378920.5386740.113*
H38Fd0.0269140.3496730.5165070.113*

  1. aOccupancy: 0.736(10), bOccupancy: 0.31(3), cOccupancy: 0.264(10), dOccupancy: 0.69(3).

Source of material

The title compound was prepared by the reaction of (E)-4-(benzylideneamino)-5-ethyl-2,4-dihydro-3H-1,2,4-triazole-3-thione (2 mmol) and 2-bromo-1-phenylethanone (2 mmol) in the mixture of ethanol (40 mL) and triethylamine (1 mL). The mixture was stirred at room temperature for 30 min and the product was obtained by filtration, drying and recrystallization from ethanol. The purified product was dissolved in ethanol and single crystals were obtained after 7 days by slow evaporation of the ethanol solution at room temperature.

Experimental details

All H atoms were positioned geometrically and allowed to ride on their parent atoms at distances of Csp2-H = 0.93 Å with Uiso = 1.2Ueq(parent atom), and Csp3-H = 0.96 or 0.97 Å with Uiso = 1.5Ueq(parent atom).

Comment

1,2,4-Triazoles and their numerous derivatives have been revealed to possess diverse biological activities. Furthermore, the recent literature survey showed that special attention has been given to 1,2,4-triazolo[3,4-b][1,3,4]thiadiazine derivatives, which proved to have promising biological activities, such as antitubercular, antibacterial, anti-inflammatory, anticancer, antileishmanial, and anti-AIDS [4], [5], [6], [7], [8], [9], [10], [11]. However, most studies have been focused on 3,6-disubstituted-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines, and relatively speaking, there is less research on 3,6-disubstituted-7-aroyl-6,7-dihydro-5H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines so far [12], [13], [14], [15], [16], [17], [18], [19], [20].

In the crystal structure of the title compound, there are three crystallographic independent molecules in the asymmetric unit, two of which are the molecules of the title compound and the other is a water molecule. All bond lengths and angles are in normal range. The triazole ring and the thiadiazine ring in each of the two independent molecules of the title compound are almost coplanar, with the very small dihedral angles of 7° and 4°, respectively. However, each thiadiazine ring and the two benzene rings attached to it, are approximately perpendicular to each other, owing to the resulting dihedral angles all above 77°, which should be as much as possible to minimize the steric hindrances among them. Both the S—C and C—N bond lengths are in good agreement with the values observed in related structures [21]. The short C—N bond lengths of 1.308(3) Å (N3—C10), 1.250(7) Å (N4—C17), 1.312(3) Å (N7—C28) and 1.30(5) Å (N8—C36), respectively, suggest partially localized double bonds. The free water molecule forms intermolecular NH—O and OH—N hydrogen bonds with the two molecules of the title compound. The disorder of an alkyl moiety (Table 2) is not shown for clarity.

Acknowledgements

This work was supported by the Natural Science Foundation of Zhangzhou Health Vocational College, China (Project No. ZWYZ201904).

References

1. Bruker. APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, WI, USA (2012).Suche in Google Scholar

2. Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H.: OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 42 (2009) 339–341.10.1107/S0021889808042726Suche in Google Scholar

3. Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Suche in Google Scholar PubMed

4. Li, Z. Q.; Bai, X. G.; Deng, Q.; Zhang, G. N.; Zhou, L.; Liu, Y. S.; Wang, J. X.; Wang, Y. C.: Preliminary SAR and biological evaluation of antitubercular triazolothiadiazine derivatives against drug-susceptible and drugresistant Mtb strains. Bioorg. Med. Chem. 25 (2017) 213–220.10.1016/j.bmc.2016.10.027Suche in Google Scholar PubMed

5. Iradyan, M. A.; Iradyan, N. S.; Minasyan, N. S.; Paronikyan, R. V.; Stepanyan, G. M.: Synthesis and antibacterial activity of 3,6-diaryl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines. Pharm. Chem. J. 50 (2016) 10–15.10.1007/s11094-016-1389-ySuche in Google Scholar

6. Morsy, R. M. I.; Salem, O. I. A.; Abdel-Moty, S. G.; Kafafy, A. H. N.: Synthesis, molecular modeling study and anti-inflammatory activity of novel benzimidazole derivatives with promising cyclooxygenase inhibitory properties. Der. Pharma. Chem. 8 (2016) 213–231.Suche in Google Scholar

7. Sever, B.; Altintop, M. D.; Kus, G.; Ozkurt, M.; Ozdemir, A.; Kaplancikli, Z. A.: Indomethacin based new triazolothiadiazine derivatives: synthesis, evaluation of their anticancer effects on T98 human glioma cell line related to COX-2 inhibition and docking studies. Eur. J. Med. Chem. 113 (2016) 179–186.10.1016/j.ejmech.2016.02.036Suche in Google Scholar PubMed

8. Aytac, P. S.; Durmaz, I.; Houston, D. R.; Cetin-Atalay, R.; Tozkoparan, B.: Novel triazolothiadiazines act as potent anticancer agents in liver cancer cells through Akt and ASK-1 proteins. Bioorg. Med. Chem. 24 (2016) 858–872.10.1016/j.bmc.2016.01.013Suche in Google Scholar PubMed

9. Ibrar, A.; Zaib, S.; Jabeen, F.; Iqbal, J.; Saeed, A.: Unraveling the alkaline phosphatase inhibition, anticancer, and antileishmanial potential of coumarin-triazolothiadiazine hybrids: design, synthesis, and molecular docking analysis. Arch. Pharm. Chem. Life Sci. 349 (2016) 1–13.10.1002/ardp.201500392Suche in Google Scholar PubMed

10. Winton, V. J.; Aldrich, C.; Kiessling, L. L.: Carboxylate surrogates enhance the antimycobacterial activity of UDP-galactopyranose mutase probes. ACS Infect. Dis. 2 (2016) 538–543.10.1021/acsinfecdis.6b00021Suche in Google Scholar PubMed PubMed Central

11. Khan, I.; Hameed, S.; Al-Masoudi, N. A.; Abdul-Reda, N. A.; Simpson, J.: New triazolothiadiazole and triazolothiadiazine derivatives as kinesin Eg5 and HIV inhibitors: synthesis, QSAR and modeling studies. Z. Naturforsch. 70 (2015) 47–58.10.1515/znb-2014-0162Suche in Google Scholar

12. Awad, I. M. A.; Rahman, A. E. A.; Bakite, E. A.: Synthesis and application of some new heterocyclo-s-triazole derivatives as antimicrobial agents. J. Chem. Tech. Biotechnol. 51 (1991) 483–495.10.1002/jctb.280510406Suche in Google Scholar

13. Zhang, B.; Li, Y. H.; Liu, Y.; Chen, Y. R.; Pan, E. S.; You, W. W.; Zhao, P. L.: Design, synthesis and biological evaluation of novel 1,2,4-triazolo[3,4-b][1,3,4]thiadiazines bearing furan and thiophene nucleus. Eur. J. Med. Chem. 103 (2015) 335–342.10.1016/j.ejmech.2015.08.053Suche in Google Scholar PubMed

14. Al-Etaibi, A.; John, E.; Ibrahim, M. R.; Al-Awadi, N. A.; Ibrahim, Y. A.: Stereoselective synthesis of dihydrothiadiazinoazines and dihydrothiadiazinoazoles and their pyrolytic desulfurization ring contraction. Tetrahedron 67 (2011) 6259–6274.10.1016/j.tet.2011.06.034Suche in Google Scholar

15. Gaponenko, N. I.; Kolodina, A. A.; Lesin, A. V.; Kurbatov, S. V.; Starikova, Z. A.; Nelyubina, Y. V.: Synthesis of spiro[indole-3,3′-[1,3,4]thiadiazino[3,2-a]benzimidazoles] and spiro[indole-3,6′-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines]. Russ. Chem. Bull. Int. Ed. 59 (2010) 838–844.10.1007/s11172-010-0170-8Suche in Google Scholar

16. Kolodina, A. A.; Lesin, A. V.: Intramolecular cyclization of 4-amino-3-alkylsulfanyl-1,2,4-triazoles as a method for annelation of thiadiazine and thiadiazole rings. Russ. J. Org. Chem. 45 (2009) 139–145.10.1134/S1070428009010199Suche in Google Scholar

17. Ibrahim, Y. A.; Elwahy, A. H. M.; El-Fiky, A. E. M.: Stereospecific synthesis of 6,7-dihydro-5H-1,2,4-triazolo[3,4-b] [1,3,4]thiadiazines. Heterocycl. Chem. 5 (1994) 321–325.10.1002/hc.520050402Suche in Google Scholar

18. Molina, P.; Alajarin, M.; De Vega, M. J. P.: Synthesis of 6,7-dihydro-5H-1,2,4-triazolo[3,4-b][1,3,4]thiadiazines by a C—C ring cyclization under mild conditions. J. Chem. Soc. Perkin Trans. 1 (1987) 1853–1860.10.1039/P19870001853Suche in Google Scholar

19. Fun, H. K.; Hemamalini, M.; Nithinchandra; Kalluraya, B.: Acta Crystallogr. E67 (2011) 128–129.10.1107/S1600536810049998Suche in Google Scholar PubMed PubMed Central

20. Foces-Foces, C.; Cano, F. H.; Molina, P.; Alajarin, M.; Perez de Vega, M. J.; Palazon, J.; Claramunt, R. M.; Elguero, J.: Host-guest compounds. x-ray structure, differential scanning calorimetry, and thermogravimetry of methanol, ethanol, isopropanol, tert-butanol and dioxame Inclusion compounds in 7-benzoyl-6-phenyl-6,7-dihydro-1-methyl-3-methylthio-5[formula omitted]-1.2,4-triazolo[3.4-[formula omitted]][1,3,4]thiadiazinium bromide. Tetrahedron 44 (1988) 5117–5130.10.1016/S0040-4020(01)86017-8Suche in Google Scholar

21. Zhang, L.-X.: Crystal structure of (1R,2S,3R,4S)-1-(6-(4-fluorophenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazin-3-yl)pentane-1,2,3,4,5-pentaol water (2:7). Z. Kristallogr. NCS 224 (2009) 269–271.10.1524/ncrs.2009.0119Suche in Google Scholar

Received: 2020-05-05
Accepted: 2020-05-28
Published Online: 2020-06-20
Published in Print: 2020-08-26

©2020 Qichun Ding et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Artikel in diesem Heft

  1. Frontmatter
  2. Crystal structure of isopimara-7,15-dien-3-one, C20H30O
  3. Crystal structure of bis(6-aminopyridine-2-carboxylato-κ2O,N)-copper(II), C12H10O6N4Cu
  4. Crystal structure of 5,6-diphenyldibenzo[c, g]chrysene, C38H24
  5. Poly[bis(dimethylformamide-κO)-(μ8-5,5′′-dicarboxy-[1,1′:4′,1′′-terphenyl]-2′,3,3′′,5′-tetracarboxylato-κ8O:O1:O2:O3:O4:O5:O6:O7)dizinc(II)] — dimethylformamide (1/2), C18H19N2O8Zn
  6. The crystal structure of poly[bis(N,N-dimethylformamide-κ1O)(μ4- 2′,5,5′,5′′-tetracarboxy-[1,1′:4′,1′′-terphenyl]-3,3′′-dicarboxylato-κ4O:O′:O′′:O′′′)manganese(II)] — N,N-dimethylformamide (1/2), C36H40N4O16Mn
  7. Crystal structure of N,N-dimethyl-4-((7-nitrobenzo[c][1,2,5]thiadiazol-4-yl)ethynyl)aniline, C16H12N4O2S
  8. The crystal structure of 8a-methoxy 8a-methoxy-1,5,8a,9a-tetrahydro-4H-8,9-dioxa-3a1λ4-aza-8aλ4, C18H14BNO3
  9. Crystal structure of poly[diaqua-(μ2-5-isopropoxyisophthalato-κ2O:O′)-(μ2-(1,3-bis(3,5-di(1H-imidazol-1-yl)pyridine))-κ2N:N′)cobalt(II)] monohydrate, C22H25N5O8Co
  10. The crystal structure of acetoximium 1′-hydroxy-1H,1H′-5,5′-bitetrazole-1-olate monohydrate, C5H11N9O4
  11. Crystal structure of 3-(2-ethoxy-2-oxoethyl)-1-vinyl-1H-imidazol-3-ium hexafluoridophosphate(V), C9H13F6N2O2P
  12. The crystal structure of catena-poly[(μ2-4-(benzo[d]imidazol-2-yl)benzenecarboxylato-κ2N,O)-(μ2-4-(benzo[d]imidazol-2-yl)benzenecarboxylato-κ3N,O:O′)cadmium(II)]dihydrate, C28H22CdN4O6
  13. Enzyme-mediated synthesis and crystal structure of (2R,4S)-hydroxyketamine, C13H16ClNO2
  14. The crystal structure of bis(isothiocyanato-κ1N)-(methanol-κ1O)-[2-morpholine-4-yl-4,6-di(pyrazol-1-yl)-1,3,5-triazine-κ3N,N′,N′′] manganese(II), C16H18MnN10O2S2
  15. Crystal structure of bis{5-chloro-2-(((4-trifluoromethyl)imino)methyl)phenolato-κ2N,O}copper(II), C28H16Cl2CuF6N2O2
  16. Crystal structure of bis(1,3-phenylenedimethanaminium) bis(triiodide) tetraiodide – water (1/2) , C8H16I5N2O
  17. Crystal structure and anti-inflammatory activity of (3E,5E)-3,5-bis(2-fluorobenzylidene)-1-((4-fluorophenyl)sulfonyl)piperidin-4-one, C25H18F3NO3S
  18. The crystal structure of bis{3-(diphenylphosphaneyl)propanoato-κ2O,P}platinum(II) dihydrate, C30H28O6P2Pt
  19. The crystal structure of (E)-2-(4-((4-fluorobenzyl)oxy)styryl)-4,6-dimethoxybenzaldehyde, C24H21FO4
  20. Crystal structure of bis[3-methoxy-N-(1-(pyrazin-2-yl)ethylidene)benzohydrazonato-κ3O,N,N′]nickel(II), C28H26N8O4Ni
  21. Crystal structure of 1-(2-(pyridin-2-yl)-5-(pyridin-3-yl)-1,3,4-oxadiazol-3(2H)-yl)ethan-1-one, C14H12N4O2
  22. Synthesis and crystal structure of 3-N-acetyl-5-(pyridin-3-yl)-2-(quinolin-2-yl)-1,3,4-oxadiazoline, C18H14N4O2
  23. Crystal structure of 2-methyl-1H-perimidine, C12H10N2
  24. Crystal structure of (E)-2-(5,5-dimethyl-3-(4-((7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)oxy)styryl)cyclohex-2-en-1-ylidene)malononitrile, C25H19N5O4
  25. Structural elucidation of 1-(3-acetyl-2,6-dihydroxy-4-methoxyphenyl)-4,5-dihydroxy-2-methylanthracene-9,10-dione isolated from Bulbine latifolia (L.) Wild, C24H18O8
  26. Crystal structure of 3-cinnamoyl-4-hydroxybenzoic acid, C16H12O4
  27. The crystal structure of poly[bis(μ4-2,3-pyridinedicarboxylato)-(μ2-oxalyl dihydrazide)-dicadmium(II) dihydrate], C16H16O12N6Cd2
  28. Synthesis and crystal structure of 1-{4-[(3-bromo-2-hydroxy-benzylidene)amino]phenyl}ethanone, C15H12BrNO2
  29. Synthesis and crystal structure of 1-{4-[(2-bromo-6-hydroxy-benzylidene)amino]phenyl}ethanone, C15H12BrNO2
  30. Crystal structure of (4-aminobenzoato-κ2O,O′)-[5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N′′,N′′′]nickel(II) perchlorate monohydrate, C23H44ClN5NiO7
  31. Crystal structure of 1-{4-[(4-fluoro-2-hydroxy-benzylidene)amino]phenyl}ethanone, C15H12FNO2
  32. Preparation and crystal structure of a non-symmetrical vanadium(II) dimer: tri-μ2-bromido-(hydrogen-tris(3-isopropyl-4-bromopyrazol-1-yl)borato-κ3N,N′,N′′)-tris(tetrahydrofuran-κO)divanadium(II) – tetrahydrofuran (1/1), C34H57BBr6N6O4V2
  33. Crystal structure of bis{2-(((4-(1-(hydroxyl-imino)ethyl)phenyl)imino)methyl)phenolato-κ2N,O}cobalt(II), C30H26CoN4O4
  34. Crystal structure of 3-((3-nitrophenyl)sulfonamido)propanoic acid — 4,4′-bipyridine (1/1), C19H18N4O6S
  35. Crystal structure of cyclo[diaqua-bis(μ2-3′,5-dicarboxy-[1,1′-biphenyl]-3,4′-dicarboxylato-κ4O,O′:O′′,O′′′)-bis(4,4′-bis(pyrid-4-yl)biphenyl-K1N)dicadmium(II)], C76H52Cd2N4O18
  36. Crystal structure of 1-(adamantan-1-yl)-3-aminothiourea, C11H19N3S
  37. Crystal structure of catena-poly[triaqua-(μ2-1,4-di(pyridin-4-yl)benzene-κ2N:N′)-(3′,5-dicarboxy-[1,1′-biphenyl]-3,4′-dicarboxylato-κO)nickel(II)], C32H26N2O11Ni
  38. Crystal structure of catena-poly[aqua-(μ4-4,4′-(pyridine-3,5-diyl)dibenzoato-κ4O,O′:O′′:O′′′)zinc(II)], C19H13NO5Zn
  39. Crystal structure of 4-(4′-(pyridin-4-yl)-[1,1′-biphenyl]-4-yl)pyridin-1-ium 2-carboxy-4-(3,5-dicarboxyphenoxy)benzoate hydrate, C38H28N2O10
  40. Crystal structure of 3-[(triisopropylsilanyl)-ethynyl]-6a,12a-dihydro-1H-1,4-diaza-benzo[α]anthracene-2,7,12-trione, C27H28N2O3Si
  41. Crystal structure of [(bis(1,10-phenanthroline-κ2N,N′)-(2-carboxy-4-(3-carboxy-5-carboxylatophenoxy)benzoato-κ2O:O′))nickel(II) monohydrate, (1,10-phenanthroline-κ2N:N′)-(μ2-(5-(3′,4′-dicarboxylphenoxy)-isophthalate-κ2O:O′))nickel(II)], C40H24N4O9Ni ⋅ H2O
  42. Crystal structure of 4-(3-(pyridin-3-yl)ureido)benzoic acid — adipic acid (2/1), C16H16N3O5
  43. Crystal structure of poly[bis{μ2-5-carboxy-4′-methyl-[1,1′-biphenyl]-3-carboxylato-κ2O:O′}-{μ2-4,4′-bipyridine-κ2N:N′}]cobalt(II), C40H30N2O8Co
  44. Crystal structure of aqua-(2,2′-bipyridine-κ2N,N′)(((3-nitrophenyl)sulfonyl)glycine-κ2N,O)copper(II) dihydrate, C18H20CuN4O9S
  45. Crystal structure of bis{2-bromo-6-(((4-(1-(methoxyimino)ethyl)phenyl)imino)methyl)phenolato-κ2N,O}copper(II), C32H28Br2CuN4O4
  46. Crystal structure of bis(2-(2-((2,6-dichlorophenyl)amino)phenyl)acetato-κ2O,O′)-(1,10-phenanthroline-κ2N,N′)zinc(II), C40H28Cl4N4O4Zn
  47. Crystal structure of 2-(3,6-dimethyl-2,3-dihydro-4H-benzo[b][1,4]oxazin-4-yl)-2-oxoethyl acetate, C14H17NO4
  48. Crystal structure of poly[dibromido-bis(μ2-1,6-di(1H-imidazol-1-yl)hexane-κ2N:N′)cadmium(II)], C24H36Br2N8Cd
  49. Synthesis and crystal structure of ((6R,7S)-3-ethyl-6-phenyl-6,7-dihydro-5H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazin-7-yl)(phenyl)methanone hemihydrate, 2(C19H18N4OS) ⋅ H2O
  50. Crystal structure of 2-(5-(pyridin-3-yl)-4-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)pyridine, C17H12N6
  51. The crystal structure of N-((1E,2E)-1,3-bis(4-fluorophenyl)but-2-en-1-ylidene)-4-methylbenzenesulfonamide, C23H19F2NO2S
  52. Crystal structure of diacetato-κ1O-diethanol-κ1O-bis(μ2-2-(((2-hydroxyethyl)imino)methyl)-5-methoxyphenolato-κ4O,N,O′:O′′)dinickel(II), C28H42Ni2N2O12
  53. The crystal structure of catena-poly[chlorido-(μ2-1,4-bis(pyridin-3-yl-methoxy)benzene-κ2N:N′)copper(II)], C18H16ClN2O2Cu
  54. N′,N′′′-(((ethane-1,2-diylbis(oxy))bis(2,1-phenylene))bis(methaneylylidene))bis(2-hydroxybenzohydrazide)nickel(II), C30H24N4NiO6
  55. Crystal structure of (E)-3′,6′-bis(ethylamino)-2′,7′-dimethyl-2-(2-((quinolin-2-ylmethylene)amino)ethyl)spiro[isoindoline-1,9′-xanthen]-3-one, C38H37N5O2
  56. Crystal structure of 4,4′-di(1H-imidazol-1-yl)-1,1′-biphenyl-1-ium 5,3′,5′-tricarboxy-[1,10-biphenyl]-2-carboxylate, C25H17N2O8
  57. The crystal structure of 1-carboxy-2-(1H-indol-3-yl)-N,N,N-trimethylethan-1-ammonium chloride, C14H19N2O2Cl
  58. The crystal structure of 5-bromo-2-fluoronicotinic acid monohydrate, C6H5BrFNO3
  59. Crystal structure of ethyl 3-(trifluoromethyl)-1H-pyrazole-4-carboxylate, C7H7F3N2O2
  60. Crystal structure of tetrakis(1H-benzo[d]imidazol-3-ium) bis(μ5-phenylphosphonato)-pentakis(μ2-oxido)-decaoxo-penta-molybdenum dihydrate, C40H42Mo5N8O23P2
  61. Structure of 7-(3,3,4,4,5,5-hexafluoro-2-(2-methylbenzo[b]thiophen-3-yl)cyclopent-1-en-1-yl)-8-methylquinoline, C24H15F6NS
  62. Crystal structure of monocarbonyl[2-((cyclopentylmethylene)amino)-5-methylphenolato-κ2N,O] (tricyclohexylphosphine)rhodium(I), C32H48NO2PRh
  63. The crystal structure of fac-tricarbonyl(1,10-phenanthroline-κ2N,N′)-(pyrazole-κN)rhenium(I)nitrate, C18H12O3N4Re
  64. Crystal structure of poly[diaqua-bis(μ2-4-(3-(pyridin-3-yl)-1H-1,2,4-triazol-5-yl)benzoato-κ2N:O)nickel(II)], C28H22O6N8Ni
  65. Crystal structure of 4,4′-bis(pyridin-1-ium-4-yl)biphenyl poly[bis(μ2-4,4′-bis(pyrid-4-yl)biphenyl-K2N:N′)-tetrakis(μ4-4′-methyl-[1,1′-biphenyl]-3,5-dicarboxylato-K4O,O′:O′′:O′′′)-bis[[μ2-1,1′-biphenyl]-3-carboxyl-5-carboxylato-K2O:O′]tetracobalt(II)]— [1,1′-biphenyl]-3,5-dicarboxylic acid (1/2), C93H68N3O16Co2
  66. The crystal structure of 4a-formyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydro-1-2-6a,6b,9,9,12a-heptamethylpicen-10-yl acetate, C32H50O3
  67. Crystal structure of 3,3′-(1,2-phenylenebis(methylene))bis(1-methyl-1H-imidazol-3-ium) bis(hexafluoridophosphate), C16H20F12N4P2
  68. Crystal structure of catena-poly[diaqua-(μ2-tartrato-κ4O,O′:O′′,O′′′)zinc(II)], C4H8O8Zn
  69. The crystal structure of (6aR,6bS,8aS,8bR,9S,11aS,12aS,12bS)-10-(4-acetoxy-3-methylbutyl)-6a,8a,9-trimethyl-3,4,5,6,6a,6b,7,8,8a,8b,9,10,11a,12,12a,12b-hexadecahydro-1H-naphtho[2′,1′:4,5]indeno[2,1-b]furan-4-yl acetate, C31H48O5
  70. Crystal structure of 4,4′-(oxybis(methylene))bis(bromobenzene), C14H12Br2O
  71. Crystal structure of (N,N-dimethylsulphoxide)-[N-(3-ethoxy-2-(oxide)benzylidene)-3-methoxybenzenecarbohydrazonato-κ3N,O,O′]-dioxo-molybdenum(VI), C19H22MoN2O7S
  72. Crystal structure of dichlorido-bis(dimethyl sulphoxide-κO)-bis(4-methylbenzyl-κC1)tin(IV), C20H30Cl2O2S2Sn
  73. Crystal structure of (E)-2-amino-N′-(2-hydroxy-4-(2-(piperidin-1-yl)ethoxy)benzylidene)benzohydrazide monohydrate, C21H26N4O3 ⋅ H2O
  74. Crystal structure of chloridotris(4-chlorophenyl)(dimethyl sulfoxide-κO)tin(IV), C20H18Cl4OSSn
  75. Crystal structure of catena{di-aqua-sodium-[N-(hydroxyethyl), N-isopropyl-dithiocarbamato]}n, [C6H16NNaO2S2]n
  76. Crystal structure of 2,2,4,4,6,6-hexakis(4-chlorophenyl)-1,3,5,2,4,6-trithiatristanninane, C36H24Cl6S3Sn3
  77. Crystal structure of 6-methoxy-3-(5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl)-4H-chromen-4-one-methanol (1/1), C20H18N2O6
  78. Crystal structure of hexanedihydrazide, C6H14N4O2
  79. Crystal structure of tert-butyl 2-(hydroxymethyl)-5-{4-[(methoxycarbonyl)amino]phenyl}-2,5-dihydro-1H-pyrrole-1-carboxylate, C18H24N2O5
  80. Crystal structure of [(Z)-O-isopropyl N-(4-nitrophenyl)thiocarbamato-κS]-(triphenylphosphine-κP)-gold(I), C28H26AuN2O3PS
  81. Crystal structure of [O-ethyl N-(4-nitrophenyl)thiocarbamato-κS](tri-4-tolylphosphine-κP)gold(I) tetrahydrofuran solvate, C30H30AuN2O3PS, C4H8O
https://doi.org/10.1515/ncrs-2020-0219
Creative Commons
BY 4.0

Artikel in diesem Heft

  1. Frontmatter
  2. Crystal structure of isopimara-7,15-dien-3-one, C20H30O
  3. Crystal structure of bis(6-aminopyridine-2-carboxylato-κ2O,N)-copper(II), C12H10O6N4Cu
  4. Crystal structure of 5,6-diphenyldibenzo[c, g]chrysene, C38H24
  5. Poly[bis(dimethylformamide-κO)-(μ8-5,5′′-dicarboxy-[1,1′:4′,1′′-terphenyl]-2′,3,3′′,5′-tetracarboxylato-κ8O:O1:O2:O3:O4:O5:O6:O7)dizinc(II)] — dimethylformamide (1/2), C18H19N2O8Zn
  6. The crystal structure of poly[bis(N,N-dimethylformamide-κ1O)(μ4- 2′,5,5′,5′′-tetracarboxy-[1,1′:4′,1′′-terphenyl]-3,3′′-dicarboxylato-κ4O:O′:O′′:O′′′)manganese(II)] — N,N-dimethylformamide (1/2), C36H40N4O16Mn
  7. Crystal structure of N,N-dimethyl-4-((7-nitrobenzo[c][1,2,5]thiadiazol-4-yl)ethynyl)aniline, C16H12N4O2S
  8. The crystal structure of 8a-methoxy 8a-methoxy-1,5,8a,9a-tetrahydro-4H-8,9-dioxa-3a1λ4-aza-8aλ4, C18H14BNO3
  9. Crystal structure of poly[diaqua-(μ2-5-isopropoxyisophthalato-κ2O:O′)-(μ2-(1,3-bis(3,5-di(1H-imidazol-1-yl)pyridine))-κ2N:N′)cobalt(II)] monohydrate, C22H25N5O8Co
  10. The crystal structure of acetoximium 1′-hydroxy-1H,1H′-5,5′-bitetrazole-1-olate monohydrate, C5H11N9O4
  11. Crystal structure of 3-(2-ethoxy-2-oxoethyl)-1-vinyl-1H-imidazol-3-ium hexafluoridophosphate(V), C9H13F6N2O2P
  12. The crystal structure of catena-poly[(μ2-4-(benzo[d]imidazol-2-yl)benzenecarboxylato-κ2N,O)-(μ2-4-(benzo[d]imidazol-2-yl)benzenecarboxylato-κ3N,O:O′)cadmium(II)]dihydrate, C28H22CdN4O6
  13. Enzyme-mediated synthesis and crystal structure of (2R,4S)-hydroxyketamine, C13H16ClNO2
  14. The crystal structure of bis(isothiocyanato-κ1N)-(methanol-κ1O)-[2-morpholine-4-yl-4,6-di(pyrazol-1-yl)-1,3,5-triazine-κ3N,N′,N′′] manganese(II), C16H18MnN10O2S2
  15. Crystal structure of bis{5-chloro-2-(((4-trifluoromethyl)imino)methyl)phenolato-κ2N,O}copper(II), C28H16Cl2CuF6N2O2
  16. Crystal structure of bis(1,3-phenylenedimethanaminium) bis(triiodide) tetraiodide – water (1/2) , C8H16I5N2O
  17. Crystal structure and anti-inflammatory activity of (3E,5E)-3,5-bis(2-fluorobenzylidene)-1-((4-fluorophenyl)sulfonyl)piperidin-4-one, C25H18F3NO3S
  18. The crystal structure of bis{3-(diphenylphosphaneyl)propanoato-κ2O,P}platinum(II) dihydrate, C30H28O6P2Pt
  19. The crystal structure of (E)-2-(4-((4-fluorobenzyl)oxy)styryl)-4,6-dimethoxybenzaldehyde, C24H21FO4
  20. Crystal structure of bis[3-methoxy-N-(1-(pyrazin-2-yl)ethylidene)benzohydrazonato-κ3O,N,N′]nickel(II), C28H26N8O4Ni
  21. Crystal structure of 1-(2-(pyridin-2-yl)-5-(pyridin-3-yl)-1,3,4-oxadiazol-3(2H)-yl)ethan-1-one, C14H12N4O2
  22. Synthesis and crystal structure of 3-N-acetyl-5-(pyridin-3-yl)-2-(quinolin-2-yl)-1,3,4-oxadiazoline, C18H14N4O2
  23. Crystal structure of 2-methyl-1H-perimidine, C12H10N2
  24. Crystal structure of (E)-2-(5,5-dimethyl-3-(4-((7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)oxy)styryl)cyclohex-2-en-1-ylidene)malononitrile, C25H19N5O4
  25. Structural elucidation of 1-(3-acetyl-2,6-dihydroxy-4-methoxyphenyl)-4,5-dihydroxy-2-methylanthracene-9,10-dione isolated from Bulbine latifolia (L.) Wild, C24H18O8
  26. Crystal structure of 3-cinnamoyl-4-hydroxybenzoic acid, C16H12O4
  27. The crystal structure of poly[bis(μ4-2,3-pyridinedicarboxylato)-(μ2-oxalyl dihydrazide)-dicadmium(II) dihydrate], C16H16O12N6Cd2
  28. Synthesis and crystal structure of 1-{4-[(3-bromo-2-hydroxy-benzylidene)amino]phenyl}ethanone, C15H12BrNO2
  29. Synthesis and crystal structure of 1-{4-[(2-bromo-6-hydroxy-benzylidene)amino]phenyl}ethanone, C15H12BrNO2
  30. Crystal structure of (4-aminobenzoato-κ2O,O′)-[5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N′′,N′′′]nickel(II) perchlorate monohydrate, C23H44ClN5NiO7
  31. Crystal structure of 1-{4-[(4-fluoro-2-hydroxy-benzylidene)amino]phenyl}ethanone, C15H12FNO2
  32. Preparation and crystal structure of a non-symmetrical vanadium(II) dimer: tri-μ2-bromido-(hydrogen-tris(3-isopropyl-4-bromopyrazol-1-yl)borato-κ3N,N′,N′′)-tris(tetrahydrofuran-κO)divanadium(II) – tetrahydrofuran (1/1), C34H57BBr6N6O4V2
  33. Crystal structure of bis{2-(((4-(1-(hydroxyl-imino)ethyl)phenyl)imino)methyl)phenolato-κ2N,O}cobalt(II), C30H26CoN4O4
  34. Crystal structure of 3-((3-nitrophenyl)sulfonamido)propanoic acid — 4,4′-bipyridine (1/1), C19H18N4O6S
  35. Crystal structure of cyclo[diaqua-bis(μ2-3′,5-dicarboxy-[1,1′-biphenyl]-3,4′-dicarboxylato-κ4O,O′:O′′,O′′′)-bis(4,4′-bis(pyrid-4-yl)biphenyl-K1N)dicadmium(II)], C76H52Cd2N4O18
  36. Crystal structure of 1-(adamantan-1-yl)-3-aminothiourea, C11H19N3S
  37. Crystal structure of catena-poly[triaqua-(μ2-1,4-di(pyridin-4-yl)benzene-κ2N:N′)-(3′,5-dicarboxy-[1,1′-biphenyl]-3,4′-dicarboxylato-κO)nickel(II)], C32H26N2O11Ni
  38. Crystal structure of catena-poly[aqua-(μ4-4,4′-(pyridine-3,5-diyl)dibenzoato-κ4O,O′:O′′:O′′′)zinc(II)], C19H13NO5Zn
  39. Crystal structure of 4-(4′-(pyridin-4-yl)-[1,1′-biphenyl]-4-yl)pyridin-1-ium 2-carboxy-4-(3,5-dicarboxyphenoxy)benzoate hydrate, C38H28N2O10
  40. Crystal structure of 3-[(triisopropylsilanyl)-ethynyl]-6a,12a-dihydro-1H-1,4-diaza-benzo[α]anthracene-2,7,12-trione, C27H28N2O3Si
  41. Crystal structure of [(bis(1,10-phenanthroline-κ2N,N′)-(2-carboxy-4-(3-carboxy-5-carboxylatophenoxy)benzoato-κ2O:O′))nickel(II) monohydrate, (1,10-phenanthroline-κ2N:N′)-(μ2-(5-(3′,4′-dicarboxylphenoxy)-isophthalate-κ2O:O′))nickel(II)], C40H24N4O9Ni ⋅ H2O
  42. Crystal structure of 4-(3-(pyridin-3-yl)ureido)benzoic acid — adipic acid (2/1), C16H16N3O5
  43. Crystal structure of poly[bis{μ2-5-carboxy-4′-methyl-[1,1′-biphenyl]-3-carboxylato-κ2O:O′}-{μ2-4,4′-bipyridine-κ2N:N′}]cobalt(II), C40H30N2O8Co
  44. Crystal structure of aqua-(2,2′-bipyridine-κ2N,N′)(((3-nitrophenyl)sulfonyl)glycine-κ2N,O)copper(II) dihydrate, C18H20CuN4O9S
  45. Crystal structure of bis{2-bromo-6-(((4-(1-(methoxyimino)ethyl)phenyl)imino)methyl)phenolato-κ2N,O}copper(II), C32H28Br2CuN4O4
  46. Crystal structure of bis(2-(2-((2,6-dichlorophenyl)amino)phenyl)acetato-κ2O,O′)-(1,10-phenanthroline-κ2N,N′)zinc(II), C40H28Cl4N4O4Zn
  47. Crystal structure of 2-(3,6-dimethyl-2,3-dihydro-4H-benzo[b][1,4]oxazin-4-yl)-2-oxoethyl acetate, C14H17NO4
  48. Crystal structure of poly[dibromido-bis(μ2-1,6-di(1H-imidazol-1-yl)hexane-κ2N:N′)cadmium(II)], C24H36Br2N8Cd
  49. Synthesis and crystal structure of ((6R,7S)-3-ethyl-6-phenyl-6,7-dihydro-5H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazin-7-yl)(phenyl)methanone hemihydrate, 2(C19H18N4OS) ⋅ H2O
  50. Crystal structure of 2-(5-(pyridin-3-yl)-4-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)pyridine, C17H12N6
  51. The crystal structure of N-((1E,2E)-1,3-bis(4-fluorophenyl)but-2-en-1-ylidene)-4-methylbenzenesulfonamide, C23H19F2NO2S
  52. Crystal structure of diacetato-κ1O-diethanol-κ1O-bis(μ2-2-(((2-hydroxyethyl)imino)methyl)-5-methoxyphenolato-κ4O,N,O′:O′′)dinickel(II), C28H42Ni2N2O12
  53. The crystal structure of catena-poly[chlorido-(μ2-1,4-bis(pyridin-3-yl-methoxy)benzene-κ2N:N′)copper(II)], C18H16ClN2O2Cu
  54. N′,N′′′-(((ethane-1,2-diylbis(oxy))bis(2,1-phenylene))bis(methaneylylidene))bis(2-hydroxybenzohydrazide)nickel(II), C30H24N4NiO6
  55. Crystal structure of (E)-3′,6′-bis(ethylamino)-2′,7′-dimethyl-2-(2-((quinolin-2-ylmethylene)amino)ethyl)spiro[isoindoline-1,9′-xanthen]-3-one, C38H37N5O2
  56. Crystal structure of 4,4′-di(1H-imidazol-1-yl)-1,1′-biphenyl-1-ium 5,3′,5′-tricarboxy-[1,10-biphenyl]-2-carboxylate, C25H17N2O8
  57. The crystal structure of 1-carboxy-2-(1H-indol-3-yl)-N,N,N-trimethylethan-1-ammonium chloride, C14H19N2O2Cl
  58. The crystal structure of 5-bromo-2-fluoronicotinic acid monohydrate, C6H5BrFNO3
  59. Crystal structure of ethyl 3-(trifluoromethyl)-1H-pyrazole-4-carboxylate, C7H7F3N2O2
  60. Crystal structure of tetrakis(1H-benzo[d]imidazol-3-ium) bis(μ5-phenylphosphonato)-pentakis(μ2-oxido)-decaoxo-penta-molybdenum dihydrate, C40H42Mo5N8O23P2
  61. Structure of 7-(3,3,4,4,5,5-hexafluoro-2-(2-methylbenzo[b]thiophen-3-yl)cyclopent-1-en-1-yl)-8-methylquinoline, C24H15F6NS
  62. Crystal structure of monocarbonyl[2-((cyclopentylmethylene)amino)-5-methylphenolato-κ2N,O] (tricyclohexylphosphine)rhodium(I), C32H48NO2PRh
  63. The crystal structure of fac-tricarbonyl(1,10-phenanthroline-κ2N,N′)-(pyrazole-κN)rhenium(I)nitrate, C18H12O3N4Re
  64. Crystal structure of poly[diaqua-bis(μ2-4-(3-(pyridin-3-yl)-1H-1,2,4-triazol-5-yl)benzoato-κ2N:O)nickel(II)], C28H22O6N8Ni
  65. Crystal structure of 4,4′-bis(pyridin-1-ium-4-yl)biphenyl poly[bis(μ2-4,4′-bis(pyrid-4-yl)biphenyl-K2N:N′)-tetrakis(μ4-4′-methyl-[1,1′-biphenyl]-3,5-dicarboxylato-K4O,O′:O′′:O′′′)-bis[[μ2-1,1′-biphenyl]-3-carboxyl-5-carboxylato-K2O:O′]tetracobalt(II)]— [1,1′-biphenyl]-3,5-dicarboxylic acid (1/2), C93H68N3O16Co2
  66. The crystal structure of 4a-formyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydro-1-2-6a,6b,9,9,12a-heptamethylpicen-10-yl acetate, C32H50O3
  67. Crystal structure of 3,3′-(1,2-phenylenebis(methylene))bis(1-methyl-1H-imidazol-3-ium) bis(hexafluoridophosphate), C16H20F12N4P2
  68. Crystal structure of catena-poly[diaqua-(μ2-tartrato-κ4O,O′:O′′,O′′′)zinc(II)], C4H8O8Zn
  69. The crystal structure of (6aR,6bS,8aS,8bR,9S,11aS,12aS,12bS)-10-(4-acetoxy-3-methylbutyl)-6a,8a,9-trimethyl-3,4,5,6,6a,6b,7,8,8a,8b,9,10,11a,12,12a,12b-hexadecahydro-1H-naphtho[2′,1′:4,5]indeno[2,1-b]furan-4-yl acetate, C31H48O5
  70. Crystal structure of 4,4′-(oxybis(methylene))bis(bromobenzene), C14H12Br2O
  71. Crystal structure of (N,N-dimethylsulphoxide)-[N-(3-ethoxy-2-(oxide)benzylidene)-3-methoxybenzenecarbohydrazonato-κ3N,O,O′]-dioxo-molybdenum(VI), C19H22MoN2O7S
  72. Crystal structure of dichlorido-bis(dimethyl sulphoxide-κO)-bis(4-methylbenzyl-κC1)tin(IV), C20H30Cl2O2S2Sn
  73. Crystal structure of (E)-2-amino-N′-(2-hydroxy-4-(2-(piperidin-1-yl)ethoxy)benzylidene)benzohydrazide monohydrate, C21H26N4O3 ⋅ H2O
  74. Crystal structure of chloridotris(4-chlorophenyl)(dimethyl sulfoxide-κO)tin(IV), C20H18Cl4OSSn
  75. Crystal structure of catena{di-aqua-sodium-[N-(hydroxyethyl), N-isopropyl-dithiocarbamato]}n, [C6H16NNaO2S2]n
  76. Crystal structure of 2,2,4,4,6,6-hexakis(4-chlorophenyl)-1,3,5,2,4,6-trithiatristanninane, C36H24Cl6S3Sn3
  77. Crystal structure of 6-methoxy-3-(5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl)-4H-chromen-4-one-methanol (1/1), C20H18N2O6
  78. Crystal structure of hexanedihydrazide, C6H14N4O2
  79. Crystal structure of tert-butyl 2-(hydroxymethyl)-5-{4-[(methoxycarbonyl)amino]phenyl}-2,5-dihydro-1H-pyrrole-1-carboxylate, C18H24N2O5
  80. Crystal structure of [(Z)-O-isopropyl N-(4-nitrophenyl)thiocarbamato-κS]-(triphenylphosphine-κP)-gold(I), C28H26AuN2O3PS
  81. Crystal structure of [O-ethyl N-(4-nitrophenyl)thiocarbamato-κS](tri-4-tolylphosphine-κP)gold(I) tetrahydrofuran solvate, C30H30AuN2O3PS, C4H8O
Jetzt anmelden und 20% sparen
Institutioneller Zugang
Wie funktioniert Authentifizierung?
Haben Sie eine Idee, wie wir unsere Website verbessern können?
Bitte schreiben Sie uns.
© 2025 De Gruyter Brill
Heruntergeladen am 5.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2020-0219/html
Button zum nach oben scrollen